Delivery Order SPE2DB20D3104-SPE2DB23FV8P8
- Not listed
- This federal contract award, valued at $1,660.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mupirocin 2% Ointment, a topical antibiotic medication, to support military healthcare programs. The contract has an ultimate completion date of May 30, 2024 and is structured as a Firm Fixed Price Delivery Order, without any set-aside designation....
- This federal contract award, valued at $2,679.61, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Mupirocin 2% Cream, a pharmaceutical product, to support military treatment facilities and other government healthcare programs. This award is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,250.04, is a delivery order for the supply of Mupirocin 2% Ointment. It is a firm fixed-price contract with a performance period ending on May 28, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $5,452.08 for Mupirocin 2% Ointment on November 10, 2025, with completion scheduled for December 9, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for procuring pharmaceuticals and medical supplies for military and veteran healthcare systems. This...
- This federal contract award, valued at $5,671.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Mupirocin 2% Cream, a topical antibiotic medication, and does not have a set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. Cencora, Inc. holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,022.49 firm fixed-price delivery order is for the supply of MUPIROCIN 2% OINTMENT 22GM, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of July 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $1,405.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MUPIROCIN 2% OINTMENT 22GM, a pharmaceutical product, with a period of performance through July 25, 2024. The contract is a Firm Fixed Price Delivery Order and was not designated with any set-aside requirements, indicating open competition. AmerisourceBergen...
- This federal contract award, with ID SPE2DB25D7067|SPE2DB25FSURK, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,181.58 firm-fixed-price delivery order is for the supply of 4567514778 - MUPIROCIN 2% OINTMENT 22GM, with a completion date of March 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Mupirocin 2% Ointment 22GM, a topical antibiotic medication, valued at $1,022.03. The contract has a performance period ending on January 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,262.88 firm fixed-price delivery order is for the supply of 4563691739 - MUPIROCIN 2% CREAM 15GM, with a completion date of February 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB23FV8P8Delivery Order
This federal contract award, valued at $1,934.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mupirocin 2% Ointment, a topical antibiotic medication, with an ultimate completion date of August 17, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries. The contract award does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/16/23 |